Completed OBSERVATIONAL NCT04173520
ELRIAH Score: A Simple Score for HCC Risk Stratification in CHC Patients With Cirrhosis or Advanced Liver Fibrosis Who Achieved SVR Following DAA Therapy
Sponsor: Egyptian Liver Hospital
Conditions
HCC
Interventions
DDA
Updated 4 times since 2019 Last updated: Nov 22, 2019 Started: Jan 31, 2015 Primary completion: Aug 31, 2019 Completion: Oct 30, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on HCC, this trial is completed. The trial is conducted by Egyptian Liver Hospital and has accumulated 4 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
4 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Dec 2019 — Jan 2021 [monthly]
Completed
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Egyptian Liver Hospital
Data source: Egyptian Liver Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.